Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up

Who can take part

• Patient diagnosed with Abdominal Aortic Aneurysm (AAA), who needs endovascular aortic repair
• Patient's anatomy suits Ankura™ AAA and Cuff Stent Graft Systems, or AUI Stent Graft IFU requirements, which indicated by the following:; Adequate iliac/femoral access vessel that is compatible with the required delivery system; Non-aneurysmal proximal aortic neck length ≥15mm; Non-aneurysmal proximal aortic neck diameter of 18-32mm; Proximal aortic neck angulation ≤ 60°; Distal iliac artery anchorage zone ≥15mm; Distal iliac artery diameter of i. 8-22 mm (for Ankura™ AAA and Cuff Stent Graft Systems), OR ii. 10-16 mm (for Ankura™ AUI Stent Graft System); Morphology suitable for endovascular repair
• Patient could understand the purpose of the clinical trial, agrees to comply with the requirements of the study including the 3-year follow-up, and signed the patient informed consent, will participate in the study

Who cannot take part

• Patient with concomitant thoracic aortic or thoraco-abdominal aneurysms；
• Subject must not be participating in another study for an investigational drug and/or device that may clinically interfere with this study's endpoints
• Patient with any contraindications mentioned in the Ankura™ AAA and Cuff Stent Graft Systems, or in Ankura™ AUI Stent Graft system IFU:; Patient with acute systemic infection; Patient with mesenteric blood flow mainly supplied by the inferior mesenteric artery; Patient with accessory renal artery original from abdominal artery; Patient who has allergic reaction to the device; Patient who is not suitable for endovascular repair in vascular morphology; Patient who cannot tolerate contrast agents due to renal insufficiency; Patient who is allergic to contrast agent; Patient's aneurysms neck has thrombus; Non-aneurysmal proximal aortic neck length <15mm; Non-aneurysmal proximal aortic neck diameter <18mm or >32mm; Proximal aortic neck angulation > 60°; Distal iliac artery anchorage zone <15mm; Distal iliac artery diameter: i. For Ankura™ AAA and Cuff Stent Graft Systems: <8mm or >22mm, OR ii. For Ankura™ AUI Stent Graft system: <10mm or >16mm
• Patient with hereditary connective tissue disease, including but not limited to Marfan Syndrome or Ehlers-Danlos Syndrome
• Acute myocardial infarction or heart failure (NYHA class III and IV), respiratory failure, malignant tumor and other serious systemic diseases
• Any condition (medical or anatomic) which makes the patient not suitable for endovascular repair according to the opinion of the investigator
• Age<18 years or Age>85 years
• Patients' life expectancy < 1 year
• Pregnant or plan to be pregnant or breast feeding
• Patient with traumatic aortic injury
• Patient with uncorrectable coagulopathy
• Patient who weighs greater than 350 pounds (150kg) or cannot undergo accurate fluoroscopy examination due to obesity